{"transactions":[{"id":693255,"issuer":{"id":4564,"kind":"organization","name":"Braveheart Bio, Inc."},"owners":[{"id":25488,"kind":"person","name":"Bos Jasper","position":1,"cik":"0001897789","reported_name":"Bos Jasper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T20:30:44.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) August 5, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":18,"expiration_date":"2036-08-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001470831-26-000797","document":"wk-form4_1786134641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897789/000147083126000797/wk-form4_1786134641.xml","form_type":"4"}},{"id":1109995,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":25488,"kind":"person","name":"Bos Jasper","position":1,"cik":"0001897789","reported_name":"Bos Jasper","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T22:36:59.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option fully vests on the earlier of (i) the first anniversary of the date vesting commenced, which was June 10, 2025; or (ii) the 2026 Annual Meeting of Shareholders."}],"balance_after":22500,"derivative":{"exercise_price":3.31,"expiration_date":"2035-06-16","underlying":"Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000929638-25-002247","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897789/000092963825002247/form4.xml","form_type":"4"}},{"id":1475740,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":25488,"kind":"person","name":"Bos Jasper","position":1,"cik":"0001897789","reported_name":"Bos Jasper","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T20:05:02.000Z","date":"2024-06-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option fully vests on the earlier of (i) the first anniversary of the date vesting commenced, which was May 15, 2024; or (ii) the 2025 Annual Meeting of Shareholders."}],"balance_after":20000,"derivative":{"exercise_price":9,"expiration_date":"2034-06-15","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000929638-24-002213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897789/000092963824002213/form4.xml","form_type":"4"}}]}